BMC Neuroscience, 2019 · DOI: https://doi.org/10.1186/s12868-019-0521-9 · Published: July 23, 2019
Postoperative pain is a common issue after surgery that current pain medications don't always effectively manage. This study explores a potential new approach by targeting a specific molecule, phosphatidylinositol 3-kinase (PI3K), which is known to play a role in pain pathways. The research focuses on how blocking PI3K after surgery affects pain behavior in mice, specifically looking at the activation of another molecule called Akt in the spinal cord. The study found that inhibiting PI3K after surgery reduced pain in male mice. This reduction in pain was linked to decreased activity of Akt in the spinal cord. This suggests that targeting PI3K could be a way to better understand and treat postoperative pain, particularly in male patients.
PI3K inhibition may offer a novel, non-opioid approach to managing postoperative pain, particularly in male patients.
Further research into the PI3K/Akt pathway can improve understanding of the biological mechanisms underlying postoperative pain and sex differences in pain processing.
These findings can inform the development of targeted therapies that address specific molecular pathways involved in pain, potentially leading to more effective and personalized pain management strategies.